Drawing for REINNERVATE

USPTO serial 79094022

REINNERVATE

Reviewed by CopyMark Law Group

Reg. 4100733Status 404
Filing date
Status date
Registration date
Feb 21, 2012
Examiner
FARRELL, ANNE M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with REINNERVATE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Miriam D. Trudell

Miriam D. Trudell Sheridan Ross P.C.1560 Broadway, Suite 1200Denver, CO 80202UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biological preparations for use in the induction of cell differentiation in cell cultures and synthetic small molecules for use in the induction of in-vitro cell differentiation, other than medical; cell growth media for growing cells for use in scientific research; media for cell culture for use, namely, in non-medical research and biotechnological laboratories; chemical preparations for biotechnological purposes, namely, for the induction of cell differentiation, in particular stem cell differentiation; reagents for use in scientific apparatus for chemical or biological analysis; chemical preparations, agents and reagents for use in cellular research; biochemicals, namely, monoclonal antibodies other than for medical or veterinary purposes; biochemicals, namely, antibodies for diagnostic, laboratory, industrial or scientific use other than medical; biochemical products containing antibodies for use in scientific researchSECTION 71 - CANCELLED
005Pharmaceutical preparations for the treatment of skin and neuro-degenerative diseases; medical biological reagents for use in molecular biology; medical diagnostic reagents; medical diagnostic reagents for in vitro laboratory tests; chemical reagents for medical and veterinary purposes; chemical preparations, agents and reagents for medical and veterinary use, namely, in the differentiation of cell types; biological preparations for the treatment of skin and neuro-degenerative diseases; cell growth media for growing cells for medical or clinical use; diagnostic agents, preparations and substances for medical purposes, namely, for use in binding or detecting antibodies, and in the development of antibodiesSECTION 71 - CANCELLED
009Cell culture apparatus and instruments for laboratory or research medical use; laboratory apparatus, namely, cell culture vessels, multiwell plates, petri dishes, cell culture well inserts, cell factories, cell culture flasks and bioreactors for use in the separation of antibodies; reaction units, namely, cell based assays, routine cell cultures, cell passaging and perfusion cell culture systems containing chemical or biological reagents; cell culture scaffolds, namely, microspun fibres and microporous polystyrene substrates coated with extra-cellular matrices; deep well plates, namely, deep reservoir petri dishes with and without well insert cradles used in laboratory researchSECTION 71 - CANCELLED
040Batch biological and chemical treatment services of materials; batch biological and chemical material treatment involving cell culture processes and the differentiation of cell types; treatment of human, animal and plant cells, bacteria and antibody materials by culturing such cells in three dimensions; material treatment involving three dimensional cell culture processes and in-vitro stem cell differentiationSECTION 71 - CANCELLED
041Education services, namely, provision of training, arranging and conducting of seminars and workshops all in the fields of biology, biotechnology, cell culture, cell biology, toxicity and safety testing, tissue and disease modelling and drug efficacy; on-line non-downloadable electronic publications, namely, bulletins and journal articles in the fields of biology, biotechnology, cell culture, cell biology, toxicity and safety testing, tissue and disease modelling and drug efficacySECTION 71 - CANCELLED
042Scientific research and design services in the field of three dimensional cell culture and analytical processes; industrial analysis and research services in the field of cell culture, cell biology, toxicity and safety testing, tissue and disease modelling and drug efficacy; laboratory services, namely, analysis and research in the field of cell and tissue cultures and their treatment; biotechnology research; laboratory services relating to the production of antibodies; growing cell cultures for research purposes; testing pharmaceutical, medical and biological agents for others; consultancy relating to biotechnologySECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 25, 2021DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sep 25, 2021DETHDEATH OF INTERNATIONAL REGISTRATION
Nov 30, 2019INNTTOTAL INVALIDATION PROCESSED BY THE IB
Jun 22, 2019INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 22, 2019INPCINVALIDATION PROCESSED
May 28, 2019INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 28, 2018C71TCANCELLED SECTION 71
Sep 29, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED
Feb 21, 2017REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 22, 2012FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Sep 5, 2012FICSFINAL DISPOSITION NOTICE SENT TO IB
Sep 4, 2012FIMPFINAL DISPOSITION PROCESSED
May 21, 2012FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 21, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 6, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 6, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 16, 2011NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 28, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 28, 2011ALIEASSIGNED TO LIE
Sep 30, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 22, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 22, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 22, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 17, 2011RFNTREFUSAL PROCESSED BY IB
Mar 30, 2011RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 30, 2011RFRRREFUSAL PROCESSED BY MPU
Mar 30, 2011RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 29, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 26, 2011MAFRAPPLICATION FILING RECEIPT MAILED
Mar 22, 2011DOCKASSIGNED TO EXAMINER
Mar 22, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 17, 2011REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance